Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bobby Gaspar Insider Profile
4 Followers
Bobby Gaspar, CEO, Director at Orchard Therapeutics, holds 0.00 shares in Orchard Therapeutics (Ticker: ORTX).
Bobby Gaspar Orchard Therapeutics (ORTX)CEO, Director
Orchard Therapeutics (ORTX)
CEO, Director
Not Ranked
Bobby Gaspar has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Bobby Gaspar does not currently own shares as a corporate insider.
A breakdown of Bobby Gaspar's holdings
Insider Roles
Bobby Gaspar does not currently hold a role as a corporate insider.
Roles that Bobby Gaspar holds in companies
Most Profitable Insider Trade
Stock:
Orchard Therapeutics
(ORTX)
(ORTX)
Rating:Informative Buy
Date:Apr 05, 2022 - Apr 05, 2023
Return:-31.30%
The most profitable trade made by Bobby Gaspar
Bobby Gaspar's Trading History
List of latest transactions for each holding click on a transaction to see Bobby Gaspar's performance on stock
You May Also Like
Bobby Gaspar insider profile FAQ
What is the percentage of profitable transactions made by Bobby Gaspar?
The percentage of profitable transactions made by Bobby Gaspar is ―.
What is the average return per transaction made by Bobby Gaspar?
The average return per transaction made by Bobby Gaspar is ―.
What stocks does Bobby Gaspar hold?
Bobby Gaspar holds: ORTX stocks.
What was Bobby Gaspar’s latest transaction?
Bobby Gaspar latest transaction was an Uninformative Sell of ―.
What was Bobby Gaspar's most profitable transaction?
Bobby Gaspar’s most profitable transaction was an Informative Buy of ORTX stock on April 5, 2022. The return on the trade was -31.30%.
What is Bobby Gaspar's role in Orchard Therapeutics?
Bobby Gaspar's role in Orchard Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.